SCHEMBL25528944

SCHEMBL25528944

Cc1ccnc2ccc(-c3c(-c4ccc(F)cc4F)nc(N)/c(=N/N)n3N)cc12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 1/20 0.36
▸ NPC1 O15118 1/20 0.36
▸ HCRTR1 O43613 1/20 0.36
▸ USP2 O75604 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ HPGD P15428 1/20 0.36
▸ TSHR P16473 1/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ CASP3 P42574 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36
▸ SENP8 Q96LD8 1/20 0.36
▸ HSD17B10 Q99714 1/20 0.36
▸ SENP7 Q9BQF6 1/20 0.36
▸ SENP6 Q9GZR1 1/20 0.36
▸ MAPK9 P45984 6/20 0.35
▸ CSNK1D P48730 6/20 0.35
▸ MAP4K4 O95819 5/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25528882 0.89 SMN1; SMN2 (0.39) KDM4ENPC1HCRTR1USP2ALDH1A1
SCHEMBL30359459 0.81 MAP4K4 (0.38) KDM4ENPC1HCRTR1USP2ALDH1A1
SCHEMBL25230127 0.81 MAP4K4 (0.38) KDM4ENPC1HCRTR1USP2ALDH1A1
SCHEMBL20392653 0.76 ADORA2A (0.44) KDM4ENPC1HCRTR1USP2ALDH1A1
SCHEMBL25528998 0.74 ADORA2A (0.41) KDM4ENPC1HCRTR1USP2ALDH1A1
SCHEMBL30359478 0.69 MAPK14 (0.40) KDM4ENPC1HCRTR1USP2ALDH1A1
SCHEMBL25206204 0.69 MAPK14 (0.40) KDM4ENPC1HCRTR1USP2ALDH1A1
SCHEMBL25528890 0.69 MAPK14 (0.47) MAPK1MAPK9CSNK1DPRKD2FGFR1
SCHEMBL20600598 0.69 GRIA1 (0.48) ADORA2A
SCHEMBL20666043 0.68 MAPK14 (0.43) KDM4ENPC1HCRTR1USP2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023091604-A1 ADENOSINE RECEPTOR ANTAGONISTS CROSSIGNAL THERAPEUTICS, INC. (US) 2023-05-25 — — WO disclosed
Send feedback